India: Healthcare

Assume your doctor prescribes a drug to you. The brand-name version costs $300 a month. Another generic drug on the other hand will cost $30. As most people would, you would also purchase the cheaper one. That generic cheaper bottle exists as a result of a delicate legal balancing act, an act that the U.S. Supreme Court is now reconsidering in a case that could change pharmaceutical competition for decades.

The life sciences and healthcare industry in India continues to evolve through regulatory and policy developments. In March 2026, key developments included proposed frameworks for post-approval...

M&A transactions in India's hospital sector whether structured as acquisitions, platform consolidations, joint ventures or minority investments, operate within a legal and regulatory framework that differs materially from conventional corporate transactions.